GleamWall
中文EN

LUNG Pulmonx Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1127537 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.2%
TTM net income YoY25.0%
TTM EPS YoY28.4%
Revenue 3-yr CAGR11.1%
Net income 3-yr CAGR—

Margins

Gross margin77.4%
Operating margin-44.4%
Net margin-47.9%
FCF margin-28.8%
EBITDA margin-43.4%

Returns

ROE-90.3%
ROA-34.2%
ROIC (approx.)-155.9%
Asset turnover0.71x

Leverage & solvency

Liabilities / assets69.0%
Debt / equity1.11x
Current ratio4.05x
Interest coverage-9.39x

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-13.7%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$90.50M$83.79M
Cost of revenue$23.36M$21.79M
Gross profit$67.14M$62.00M
R&D expense$19.49M$17.57M
SG&A expense$101.31M$102.14M
Operating income-$53.66M-$57.70M
Interest expense$3.15M$3.51M
Pretax income-$53.38M-$55.89M
Income tax$626,000$500,000
Net income-$54.00M-$56.39M
EBITDA-$52.56M-$56.60M
EPS (basic)-1.33-1.44
EPS (diluted)-1.33-1.44
Weighted avg. shares (diluted)40.69M39.11M
Balance sheet
Cash & equivalents$69.75M$71.16M
Receivables$12.07M$13.12M
Inventory$15.85M$16.91M
Current assets$101.68M$136.25M
PP&E, net$2.22M$2.91M
Goodwill$2.33M$2.33M
Intangibles—$0
Total assets$129.29M$162.85M
Current liabilities$20.06M$24.44M
Short-term debt$106,000$3.18M
Long-term debt$36.99M$34.00M
Total debt$37.09M$37.18M
Total liabilities$75.17M$77.04M
Shareholders' equity$54.12M$85.81M
Net debt-$32.66M-$33.98M
Shares outstanding41.67M39.79M
Cash flow statement
Operating cash flow-$32.38M-$31.54M
Capital expenditure$452,000$1.45M
Free cash flow-$32.83M-$32.98M
Investing cash flow$30.48M$17.48M
Financing cash flow$833,000$1.36M
Depreciation & amortization$1.10M$1.10M
Stock-based compensation$21.23M$22.95M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.